• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Progenics Pharmaceuticals Inc

+ Add to Watchlist

PGNX:US

3.7200 USD 0.1700 4.37%

As of 20:10:00 ET on 04/23/2014.

Company Profile for Progenics Pharmaceuticals Inc (PGNX)

Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics' principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology.

Contact Information

Progenics Pharmaceuticals Inc

777 Old Saw Mill River Road
Tarrytown, NY 10591
United States
Phone: 1-914-789-2800
Fax: 1-914-789-2817

Key Executives for Progenics Pharmaceuticals Inc (PGNX)

Peter Jeremiah CrowleyChairmanMark Robert BakerChief Executive Officer
Robert J IsraelExec VP:Medical AffairsHagop YoussoufianExec VP:Research & Development
John W BabichSenior Vice PresidentNitya G RaySenior VP:Manufacturing
Angelo W Lovallo JrVP:Finance/TreasurerVivien WongVP:Product Development
Ann Marie AssummaVP:Regulatory AffairsAmy MartiniDirector:Corporate Affairs
David E MartinGeneral Counsel

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil